New at Prodigy Blog A collection of articles about our people, our capabilities, our industry, and everything in between. Del Doherty 7/11/25 Del Doherty 7/11/25 What’s Lurking in the Dust? Read More Del Doherty 7/4/25 Del Doherty 7/4/25 GLP-1 Medications: What You Need to Know About Side Effects Read More Del Doherty 6/27/25 Del Doherty 6/27/25 Moving Beyond Blood Sugar – The Role of GLP-1s (Ozempic, Wegovy) in Cardiovascular Disease Prevention Read More Del Doherty 6/19/25 Del Doherty 6/19/25 Cardiovascular Diseases Part 2 of 2: New Frontiers in CVD Treatment (2020–2025) Read More Del Doherty 6/12/25 Del Doherty 6/12/25 Cardiovascular Disease Claims in Workers’ Comp (Part 1 of 2) Read More Del Doherty 6/8/25 Del Doherty 6/8/25 Symbravo for Migraine: Clinical Relief for Patients or Patent Extension Strategy (Pain for Payers)? Read More Older Posts
Del Doherty 7/4/25 Del Doherty 7/4/25 GLP-1 Medications: What You Need to Know About Side Effects Read More
Del Doherty 6/27/25 Del Doherty 6/27/25 Moving Beyond Blood Sugar – The Role of GLP-1s (Ozempic, Wegovy) in Cardiovascular Disease Prevention Read More
Del Doherty 6/19/25 Del Doherty 6/19/25 Cardiovascular Diseases Part 2 of 2: New Frontiers in CVD Treatment (2020–2025) Read More
Del Doherty 6/12/25 Del Doherty 6/12/25 Cardiovascular Disease Claims in Workers’ Comp (Part 1 of 2) Read More
Del Doherty 6/8/25 Del Doherty 6/8/25 Symbravo for Migraine: Clinical Relief for Patients or Patent Extension Strategy (Pain for Payers)? Read More